Cargando…
Epidemiology and Clinical Characteristics of Non-Hodgkin Lymphoma in Mexico
BACKGROUND: There is no epidemiological registry in Mexico. The information about the epidemiology in our country is obtained by these types of studies, such as multicentric studies. A lot of improvements in the survival in non-Hodgkin lymphoma patients had occurred in the last 20 years. The access...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935617/ https://www.ncbi.nlm.nih.gov/pubmed/33738003 http://dx.doi.org/10.14740/wjon1351 |
_version_ | 1783661037207158784 |
---|---|
author | Hernandez-Ruiz, Eleazar Alvarado-Ibarra, Martha Juan Lien-Chang, Lourdes Esthela Banda-Garcia, Luisa Aquino-Salgado, Jorge Luis Barragan-Ibanez, Gabriel Ramirez-Romero, Eva Fabiola Nolasco-Cancino, Cesar Herrera-Olivares, Wilfrido Morales-Adrian, Javier de Jesus Paredes-Lozano, Eugenia Patricia Espitia-Rios, Maria Eugenia Gonzalez Lopez-Elizalde, Maria de Monserrat Lopez-Arroyo, Jose Luis Trejo-Gomora, Jorge Enrique De la Pena-Celaya, Jose Antonio Alvarez-Vera, Jose Luis Arana-Luna, Luara Luz Martinez-Rios, Annel Resendiz-Olea, Rodrigo Rodriguez-Velasquez, Lucero Jazmin Zapata-Canto, Nidia Perez-Zuniga, Juan Manuel |
author_facet | Hernandez-Ruiz, Eleazar Alvarado-Ibarra, Martha Juan Lien-Chang, Lourdes Esthela Banda-Garcia, Luisa Aquino-Salgado, Jorge Luis Barragan-Ibanez, Gabriel Ramirez-Romero, Eva Fabiola Nolasco-Cancino, Cesar Herrera-Olivares, Wilfrido Morales-Adrian, Javier de Jesus Paredes-Lozano, Eugenia Patricia Espitia-Rios, Maria Eugenia Gonzalez Lopez-Elizalde, Maria de Monserrat Lopez-Arroyo, Jose Luis Trejo-Gomora, Jorge Enrique De la Pena-Celaya, Jose Antonio Alvarez-Vera, Jose Luis Arana-Luna, Luara Luz Martinez-Rios, Annel Resendiz-Olea, Rodrigo Rodriguez-Velasquez, Lucero Jazmin Zapata-Canto, Nidia Perez-Zuniga, Juan Manuel |
author_sort | Hernandez-Ruiz, Eleazar |
collection | PubMed |
description | BACKGROUND: There is no epidemiological registry in Mexico. The information about the epidemiology in our country is obtained by these types of studies, such as multicentric studies. A lot of improvements in the survival in non-Hodgkin lymphoma patients had occurred in the last 20 years. The access to treatment in these types of pathology could change the prognostic factors in Mexican Mestizos patients. The primary objective of the study was to learn what the most frequent histological varieties of non-Hodgkin lymphoma in Mexico are. The secondary objectives included clinical characteristics, treatments used, treatment response, disease-free survival and overall survival. METHODS: A retrospective, descriptive study of consecutive cases was carried out in 14 hospitals across 14 Mexican states with patients diagnosed with non-Hodgkin lymphoma using the World Health Organization (WHO) 2008 criteria. Inclusion criteria included: ≥ 18 years of age, male or female, any clinical stage at diagnosis, who had received any chemotherapy regimen, with a known outcome. Descriptive statistics was performed for all variables, and survival was assessed using Kaplan-Meier curves. RESULTS: Totally, 609 patients were enrolled, of which 545 were B-cell lymphomas and 64 were T-cell lymphomas. Median ages were 61 and 50, respectively. B-cell lymphomas were more common in males with 52.1%, and 65.5% of T-cell lymphomas occurred in females. For B-cell lymphomas, the two most frequent histological subtypes were diffuse large B-cell lymphoma in 63.9%, followed by follicular lymphoma at 18%. Meanwhile, 50% of T-cell lymphomas were of the T/natural killer (NK) subtype, and 87.1% of the patients received a CHOP-like regimen. Radiotherapy was given to 31% of B-cell Lymphomas and 46.9% of T-cell lymphomas. Overall survival at 9 years was 84.6% for B-cell lymphomas, and 73.4% for T-cell lymphomas. CONCLUSIONS: Diffuse large B-cell lymphoma constitutes the most frequent subtype for B-cell lymphomas in Mexico. The most frequent T-cell lymphoma is the NK/T histological subtype. |
format | Online Article Text |
id | pubmed-7935617 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elmer Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-79356172021-03-17 Epidemiology and Clinical Characteristics of Non-Hodgkin Lymphoma in Mexico Hernandez-Ruiz, Eleazar Alvarado-Ibarra, Martha Juan Lien-Chang, Lourdes Esthela Banda-Garcia, Luisa Aquino-Salgado, Jorge Luis Barragan-Ibanez, Gabriel Ramirez-Romero, Eva Fabiola Nolasco-Cancino, Cesar Herrera-Olivares, Wilfrido Morales-Adrian, Javier de Jesus Paredes-Lozano, Eugenia Patricia Espitia-Rios, Maria Eugenia Gonzalez Lopez-Elizalde, Maria de Monserrat Lopez-Arroyo, Jose Luis Trejo-Gomora, Jorge Enrique De la Pena-Celaya, Jose Antonio Alvarez-Vera, Jose Luis Arana-Luna, Luara Luz Martinez-Rios, Annel Resendiz-Olea, Rodrigo Rodriguez-Velasquez, Lucero Jazmin Zapata-Canto, Nidia Perez-Zuniga, Juan Manuel World J Oncol Original Article BACKGROUND: There is no epidemiological registry in Mexico. The information about the epidemiology in our country is obtained by these types of studies, such as multicentric studies. A lot of improvements in the survival in non-Hodgkin lymphoma patients had occurred in the last 20 years. The access to treatment in these types of pathology could change the prognostic factors in Mexican Mestizos patients. The primary objective of the study was to learn what the most frequent histological varieties of non-Hodgkin lymphoma in Mexico are. The secondary objectives included clinical characteristics, treatments used, treatment response, disease-free survival and overall survival. METHODS: A retrospective, descriptive study of consecutive cases was carried out in 14 hospitals across 14 Mexican states with patients diagnosed with non-Hodgkin lymphoma using the World Health Organization (WHO) 2008 criteria. Inclusion criteria included: ≥ 18 years of age, male or female, any clinical stage at diagnosis, who had received any chemotherapy regimen, with a known outcome. Descriptive statistics was performed for all variables, and survival was assessed using Kaplan-Meier curves. RESULTS: Totally, 609 patients were enrolled, of which 545 were B-cell lymphomas and 64 were T-cell lymphomas. Median ages were 61 and 50, respectively. B-cell lymphomas were more common in males with 52.1%, and 65.5% of T-cell lymphomas occurred in females. For B-cell lymphomas, the two most frequent histological subtypes were diffuse large B-cell lymphoma in 63.9%, followed by follicular lymphoma at 18%. Meanwhile, 50% of T-cell lymphomas were of the T/natural killer (NK) subtype, and 87.1% of the patients received a CHOP-like regimen. Radiotherapy was given to 31% of B-cell Lymphomas and 46.9% of T-cell lymphomas. Overall survival at 9 years was 84.6% for B-cell lymphomas, and 73.4% for T-cell lymphomas. CONCLUSIONS: Diffuse large B-cell lymphoma constitutes the most frequent subtype for B-cell lymphomas in Mexico. The most frequent T-cell lymphoma is the NK/T histological subtype. Elmer Press 2021-02 2021-02-24 /pmc/articles/PMC7935617/ /pubmed/33738003 http://dx.doi.org/10.14740/wjon1351 Text en Copyright 2021, Hernandez-Ruiz et al. http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Hernandez-Ruiz, Eleazar Alvarado-Ibarra, Martha Juan Lien-Chang, Lourdes Esthela Banda-Garcia, Luisa Aquino-Salgado, Jorge Luis Barragan-Ibanez, Gabriel Ramirez-Romero, Eva Fabiola Nolasco-Cancino, Cesar Herrera-Olivares, Wilfrido Morales-Adrian, Javier de Jesus Paredes-Lozano, Eugenia Patricia Espitia-Rios, Maria Eugenia Gonzalez Lopez-Elizalde, Maria de Monserrat Lopez-Arroyo, Jose Luis Trejo-Gomora, Jorge Enrique De la Pena-Celaya, Jose Antonio Alvarez-Vera, Jose Luis Arana-Luna, Luara Luz Martinez-Rios, Annel Resendiz-Olea, Rodrigo Rodriguez-Velasquez, Lucero Jazmin Zapata-Canto, Nidia Perez-Zuniga, Juan Manuel Epidemiology and Clinical Characteristics of Non-Hodgkin Lymphoma in Mexico |
title | Epidemiology and Clinical Characteristics of Non-Hodgkin Lymphoma in Mexico |
title_full | Epidemiology and Clinical Characteristics of Non-Hodgkin Lymphoma in Mexico |
title_fullStr | Epidemiology and Clinical Characteristics of Non-Hodgkin Lymphoma in Mexico |
title_full_unstemmed | Epidemiology and Clinical Characteristics of Non-Hodgkin Lymphoma in Mexico |
title_short | Epidemiology and Clinical Characteristics of Non-Hodgkin Lymphoma in Mexico |
title_sort | epidemiology and clinical characteristics of non-hodgkin lymphoma in mexico |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935617/ https://www.ncbi.nlm.nih.gov/pubmed/33738003 http://dx.doi.org/10.14740/wjon1351 |
work_keys_str_mv | AT hernandezruizeleazar epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico AT alvaradoibarramartha epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico AT juanlienchanglourdesesthela epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico AT bandagarcialuisa epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico AT aquinosalgadojorgeluis epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico AT barraganibanezgabriel epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico AT ramirezromeroevafabiola epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico AT nolascocancinocesar epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico AT herreraolivareswilfrido epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico AT moralesadrianjavierdejesus epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico AT paredeslozanoeugeniapatricia epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico AT espitiariosmariaeugenia epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico AT gonzalezlopezelizaldemariademonserrat epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico AT lopezarroyojoseluis epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico AT trejogomorajorgeenrique epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico AT delapenacelayajoseantonio epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico AT alvarezverajoseluis epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico AT aranalunaluaraluz epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico AT martinezriosannel epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico AT resendizolearodrigo epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico AT rodriguezvelasquezlucerojazmin epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico AT zapatacantonidia epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico AT perezzunigajuanmanuel epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico |